Mitochondrial protein IF1 is a potential regulator of glucagon-like peptide (GLP-1) secretion function of the mouse intestine
IF1 (ATPIF1) is a nuclear DNA-encoded mitochondrial protein whose activity is inhibition of the F1Fo-ATP synthase to control ATP production. IF1 activity remains unknown in the regulation of GLP-1 activity. In this study, IF1 was examined in the diet-induced obese mice using the gene knockout (If1-K...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_914c24ffd30c45d19e4ab704f7d98bbc | ||
042 | |a dc | ||
100 | 1 | 0 | |a Ying Wang |e author |
700 | 1 | 0 | |a Jiaojiao Zhang |e author |
700 | 1 | 0 | |a Xinyu Cao |e author |
700 | 1 | 0 | |a Yaya Guan |e author |
700 | 1 | 0 | |a Shuang Shen |e author |
700 | 1 | 0 | |a Genshen Zhong |e author |
700 | 1 | 0 | |a Xiwen Xiong |e author |
700 | 1 | 0 | |a Yanhong Xu |e author |
700 | 1 | 0 | |a Xiaoying Zhang |e author |
700 | 1 | 0 | |a Hui Wang |e author |
700 | 1 | 0 | |a Jianping Ye |e author |
245 | 0 | 0 | |a Mitochondrial protein IF1 is a potential regulator of glucagon-like peptide (GLP-1) secretion function of the mouse intestine |
260 | |b Elsevier, |c 2021-06-01T00:00:00Z. | ||
500 | |a 2211-3835 | ||
500 | |a 10.1016/j.apsb.2021.02.002 | ||
520 | |a IF1 (ATPIF1) is a nuclear DNA-encoded mitochondrial protein whose activity is inhibition of the F1Fo-ATP synthase to control ATP production. IF1 activity remains unknown in the regulation of GLP-1 activity. In this study, IF1 was examined in the diet-induced obese mice using the gene knockout (If1-KO) mice. The mice gained more body weight on a high fat diet without a change in food intake. Insulin tolerance was impaired, but the oral glucose tolerance was improved through an increase in GLP-1 secretion. The KO mice exhibited an improved intestine structure, mitochondrial superstructure, enhanced mitophagy, reduced apoptosis and decreased adenine nucleotide translocase 2 (ANT2) protein in the intestinal epithelial cells together with preserved gut microbiota. The data suggest that GLP-1 secretion was enhanced in the obese If1-KO mice to preserve glucose tolerance through a signaling pathway of ANT2/mitochondria/L-cells/GLP-1/insulin. IF1 is a potential mitochondrial target for induction of GLP-1 secretion in L-cells. | ||
546 | |a EN | ||
690 | |a GLP-1 | ||
690 | |a ATPIF1 | ||
690 | |a ANT2 | ||
690 | |a L-cells | ||
690 | |a Mitophagy | ||
690 | |a Microbiota | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Acta Pharmaceutica Sinica B, Vol 11, Iss 6, Pp 1568-1577 (2021) | |
787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S221138352100040X | |
787 | 0 | |n https://doaj.org/toc/2211-3835 | |
856 | 4 | 1 | |u https://doaj.org/article/914c24ffd30c45d19e4ab704f7d98bbc |z Connect to this object online. |